Therapeutic strategy for oral cancer based on hypoxia PET imaging

基于缺氧PET成像的口腔癌治疗策略

基本信息

  • 批准号:
    22390377
  • 负责人:
  • 金额:
    $ 12.48万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2010
  • 资助国家:
    日本
  • 起止时间:
    2010 至 2012
  • 项目状态:
    已结题

项目摘要

Establishment of genetic hypoxia imaging is very critical for the treatment of oral cancer. The expression of the human sodium-iodide symporter (hNIS) gene is visualized by positron emission tomography (PET) and single photon emission computed tomography (SPECT). Our group has already established cell lines stably expressing hNIS. We established the cancer cell line stably expressing hNIS (HCT116-hNIS line B), and succeeded in imaging the mouse xenograft model by 99mTcO4SPECT. In the future, this model will provide a tool to track tumor metastasis in vivo in mice so that the molecular mechanism involved in metastatic cascade will be elucidated.
遗传缺氧成像的建立对于口腔癌的治疗非常重要。通过正电子发射断层扫描(PET)和单个光子发射计算机断层扫描(SPECT)可视化人类碘 - 碘分类器(HNIS)基因的表达。我们的小组已经建立了稳定表达HNI的细胞系。我们建立了稳定表达HNI(HCT116-HNIS B)的癌细胞系,并通过99MTCO4SPECT成功地对小鼠异种移植模型进行了成像。将来,该模型将提供一种跟踪小鼠体内肿瘤转移的工具,以便阐明参与转移性级联反应的分子机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
低酸素応答性レポーター遺伝子安定発現ヒトグリオーマ細胞株の樹立
稳定表达缺氧反应报告基因的人胶质瘤细胞系的建立
  • DOI:
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    0
  • 作者:
    村井知佳、犬伏正幸;他
  • 通讯作者:
Clinical usefulness of FDG-PET in combination with serum-soluble Interleukin-2 receptor (sIL-2R) as a prognostic factor in patients with malignant lymphoma in the head and neck
FDG-PET 联合血清可溶性白细胞介素 2 受体 (sIL-2R) 作为头颈部恶性淋巴瘤患者预后因素的临床应用
  • DOI:
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kitagawa Y;Onodera M;et al
  • 通讯作者:
    et al
Clinical usefulness of FDG-PET in combination with serum-soluble Inter leukin-2 receptor (sIL-2R) as a prognostic factor in patients with malignant lvmnhoma in the head and neck.
FDG-PET 与血清可溶性白细胞介素 2 受体 (sIL-2R) 联合作为头颈部恶性淋巴瘤患者的预后因素的临床用途。
  • DOI:
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kitagawa Y;Onodera M;et al.
  • 通讯作者:
    et al.
FDG-PET to evaluate four types of chronic osteomyelitis of Jaws in combination with conventional imaging modalities.
FDG-PET 结合传统成像方式评估四种类型的慢性颌骨骨髓炎。
  • DOI:
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kitagawa Y;Yamazaki Y;et al.
  • 通讯作者:
    et al.
Long-term effects of hepatocyte growth factor gene therapy in rat myocardial infarct model
  • DOI:
    10.1038/gt.2011.128
  • 发表时间:
    2012-08-01
  • 期刊:
  • 影响因子:
    5.1
  • 作者:
    Jin, Y-N;Inubushi, M.;Saga, T.
  • 通讯作者:
    Saga, T.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KITAGAWA Yoshimasa其他文献

Antiresorptive Agent-related Osteonecrosis of the Jaw in the Elderly with Dementia and Breast Cancer: A Case Report
患有痴呆症和乳腺癌的老年人与抗骨吸收剂相关的下颌骨坏死:一例报告

KITAGAWA Yoshimasa的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KITAGAWA Yoshimasa', 18)}}的其他基金

Novel strategy for treatment of oral cancer based on hypoxia imaging
基于缺氧成像的口腔癌治疗新策略
  • 批准号:
    19H03845
  • 财政年份:
    2019
  • 资助金额:
    $ 12.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
New strategy for oral cancer based on molecular imaging reflecting therapeutic resistance
基于分子影像反映治疗耐药性的口腔癌新策略
  • 批准号:
    16H05536
  • 财政年份:
    2016
  • 资助金额:
    $ 12.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Cell analysis in saliva by flow cytometry as a new diagnostic target for oral medicine
通过流式细胞术进行唾液细胞分析作为口腔医学的新诊断目标
  • 批准号:
    26670854
  • 财政年份:
    2014
  • 资助金额:
    $ 12.48万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
New therapeutic strategy for oral cancer based on gene response to hypoxia by molecular imaging
基于分子成像对缺氧的基因反应的口腔癌新治疗策略
  • 批准号:
    25293406
  • 财政年份:
    2013
  • 资助金额:
    $ 12.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Energy metabolism and muscle pathology in swallowing muscles after electric nerve stimulation
电神经刺激后吞咽肌的能量代谢和肌肉病理学
  • 批准号:
    24659882
  • 财政年份:
    2012
  • 资助金额:
    $ 12.48万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Energy metabolism and muscle pathology in denervated swallowing muscles
去神经吞咽肌的能量代谢和肌肉病理学
  • 批准号:
    22659361
  • 财政年份:
    2010
  • 资助金额:
    $ 12.48万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
FDG-PET to evaluate intraarterial chemoradiotherapy as organ preservation protocol in oral squamous cell carcinoma
FDG-PET 评估动脉内放化疗作为口腔鳞状细胞癌的器官保存方案
  • 批准号:
    15592103
  • 财政年份:
    2003
  • 资助金额:
    $ 12.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Novel strategies for the treatment of pral cancerbased on hypoxia assessment
基于缺氧评估的前列腺癌治疗新策略
  • 批准号:
    22H03285
  • 财政年份:
    2022
  • 资助金额:
    $ 12.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Novel strategy for treatment of oral cancer based on hypoxia imaging
基于缺氧成像的口腔癌治疗新策略
  • 批准号:
    19H03845
  • 财政年份:
    2019
  • 资助金额:
    $ 12.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
New strategy for oral cancer based on molecular imaging reflecting therapeutic resistance
基于分子影像反映治疗耐药性的口腔癌新策略
  • 批准号:
    16H05536
  • 财政年份:
    2016
  • 资助金额:
    $ 12.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Elucidation of the acquisiton mechanism of therapeutic resistance using imaging of genetic response to tumor hypoxia
利用肿瘤缺氧遗传反应成像阐明治疗耐药的获得机制
  • 批准号:
    26893005
  • 财政年份:
    2014
  • 资助金额:
    $ 12.48万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
New therapeutic strategy for oral cancer based on gene response to hypoxia by molecular imaging
基于分子成像对缺氧的基因反应的口腔癌新治疗策略
  • 批准号:
    25293406
  • 财政年份:
    2013
  • 资助金额:
    $ 12.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了